You have 9 free searches left this month | for more free features.

Interferons

Showing 1 - 25 of 1,152

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Czech Pharmaco-epidemiological Study on Disease Modifying Drugs

Completed
  • Multiple Sclerosis
  • interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
  • Prague, Czechia
    IMPULS Endowment Fund
Mar 7, 2023

Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts

Not yet recruiting
  • Warts
  • Detection of expression of SOCS3 gene
  • +2 more
  • (no location specified)
Mar 12, 2023

Stage IV Melanoma Trial in Cleveland (recombinant interferon alfa-2b, cisplatin, sodium stibogluconate)

Completed
  • Stage IV Melanoma
  • recombinant interferon alfa-2b
  • +4 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Institute, Case Comprehensive Cancer Ce
Jul 22, 2020

Long-Term Safety of Vumerity and Tecfidera in Multiple Sclerosis

Not yet recruiting
  • Multiple Sclerosis
  • Diroximel Fumarate
  • +2 more
  • (no location specified)
Mar 2, 2023

Relapsing-Remitting Multiple Sclerosis (RRMS) Trial in Italy (peginterferon beta-1a)

Completed
  • Relapsing-Remitting Multiple Sclerosis (RRMS)
  • peginterferon beta-1a
  • Arezzo, Italy
  • +29 more
Dec 24, 2019

Sarcoma, Kaposi, HIV Trial in Miami (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Interferon alfa-2a
  • +2 more
  • Miami, Florida
    Univ of Miami School of Medicine
Oct 27, 2021

Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Interferon alfa-2a
  • +2 more
  • New York, New York
    Mem Sloan - Kettering Cancer Ctr
Oct 28, 2021

COVID-19, INTERFERON, NEBULIZATION Trial in France (inhaled type I interferon, WFI water nebulization)

Recruiting
  • COVID-19
  • +2 more
  • inhaled type I interferon
  • WFI water nebulization
  • Abbeville, France
  • +6 more
Jan 3, 2022

COVID-19, SARS-CoV2 Infection Trial in New Haven (Neosporin, Vaseline)

Recruiting
  • COVID-19
  • SARS-CoV2 Infection
  • New Haven, Connecticut
    Yale University
Sep 12, 2022

Hypertrophic Scar Trial in Islamabad, Rawalpindi (Microneedling, Percutaneous Collagen Induction)

Recruiting
  • Hypertrophic Scar
  • Microneedling
  • Percutaneous Collagen Induction
  • Islamabad, Federal, Pakistan
  • +1 more
Nov 3, 2021

Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)

Recruiting
  • Essential Thrombocytopenia
  • Recombinant Interferon Alpha
  • Pegylated interferon alfa-2b
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 18, 2022

CD4/CD8+ Interferon Gamma Release Assay for Monitoring

Active, not recruiting
  • Tuberculosis
  • Interferon gamma release assay (IGRA)
  • Milano, Italy
    IRCCS San Raffaele Scientific Institute
Feb 13, 2023

Hepatocellular Carcinoma, Chronic Hepatitis B Trial in Xiamen (NAs("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") combined

Recruiting
  • Hepatocellular Carcinoma
  • Chronic Hepatitis B
  • NAs("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") combined with interferon treatments
  • NAs ("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") treatments
  • Xiamen, Fujian, China
    Boheng Zhang
Feb 7, 2023

Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)

Not yet recruiting
  • Angiosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Mar 23, 2023

Lupus Erythematosus, Systemic Trial in Beijing (low dose GR1603 in phase ?b, high dose GR1603 in phase?b, low dose GR1603 in

Recruiting
  • Lupus Erythematosus, Systemic
  • low dose GR1603 in phase Ⅰb
  • +4 more
  • Beijing, Beijing, China
    Peking union Medical Hosipital
Aug 22, 2023

Chronic Pulmonary Aspergillosis, Aspergillosis Trial (Interferon Gamma-1B 0.1 MG Per 0.5 ML Injection PLUS antifungals as

Not yet recruiting
  • Chronic Pulmonary Aspergillosis
  • Aspergillosis
  • Interferon Gamma-1B 0.1 MG Per 0.5 ML Injection PLUS antifungals as standard of care
  • Antifungals as standard of care
  • (no location specified)
Dec 13, 2022

Chronic Hepatitis B Virus Infection Trial in Worldwide (PEG-IFNa, BRII-835)

Not yet recruiting
  • Chronic Hepatitis B Virus Infection
  • Kingswood, New South Wales, Australia
  • +28 more
Jul 21, 2023

Herpes Zoster Trial (Recombinant Human Interferon a-2b Gel (After the Alteration), Recombinant Human Interferon a-2b Gel (Before

Not yet recruiting
  • Herpes Zoster
  • Recombinant Human Interferon α-2b Gel (After the Alteration)
  • Recombinant Human Interferon α-2b Gel (Before the Alteration)
  • (no location specified)
Apr 7, 2023

HPV Infection Trial (Human interferon alpha 2b vaginal Effervescent capsules)

Not yet recruiting
  • HPV Infection
  • Human interferon alpha 2b vaginal Effervescent capsules
  • (no location specified)
May 8, 2023

Blood Collection From People With Ovarian Cancer

Completed
  • Ovarian Cancer
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 7, 2022

    Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate

    Recruiting
    • Multiple Sclerosis
    • Diroximel Fumarate
    • +8 more
    • Eden Prairie, Minnesota
      OptumInsight
    Jan 9, 2023

    Acute Stroke, Acute Ischemic Stroke, Ischemic Stroke Trial in Albuquerque (Serum and Urine measurement of cytokines.)

    Completed
    • Acute Stroke
    • +3 more
    • Serum and Urine measurement of cytokines.
    • Albuquerque, New Mexico
      Department of Neurology, University of New Mexico
    Jan 25, 2022

    Pneumonia, Ventilator-Associated Trial in France (Interferon gamma, Placebo)

    Not yet recruiting
    • Pneumonia, Ventilator-Associated
    • Interferon gamma
    • Placebo
    • Lyon, France
    • +6 more
    May 2, 2023

    Kohlmeier Degos Disease With Neurologic Involvement Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

    Recruiting
    • Kohlmeier Degos Disease With Neurologic Involvement
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 23, 2023

    COVID-19 Infection and Its Clinical Prognosis in Chronic

    Recruiting
    • Chronic Hepatitis B
    • COVID-19 Infection
    • Beijing, Beijing, China
      Department of Hepatology Division 2, Beijing Ditan Hospital
    Mar 28, 2023